Skip to content

Perkins Capital Management reported holdings

Quarter ended 30 June 2026. Filed with the SEC on 24 July 2026, signed by Richard Perkins, President. Retrieved 14 October 2026. Page updated 21 October 2026.

Perkins Capital Management’s reported 13F holdings total $133M across 79 positions as of 30 June 2026. The ten largest make up 52.2% of it, and its value rose 24.6% from the prior quarter.

$133M
Reported 13F value
79
Positions
52.2%
In the 10 largest
+24.6%
Value vs. prior quarter

Largest positions

Natera Inc.COM$11M
Class
COM
Share
8.3%
Eli Lilly & COCOM$10.4M
Class
COM
Share
7.8%
Advanced Micro Devices Inc. DelCOM$8.08M
Class
COM
Share
6.1%
Butterfly Network Inc.COM$7.31M
Class
COM
Share
5.5%
Axogen Inc.COM$6.83M
Class
COM
Share
5.1%
Inuvo Inc.COM$6.49M
Class
COM
Share
4.9%
Quicklogic Corp.COM NEW$5.14M
Class
COM NEW
Share
3.9%
Idexx Labs Inc.COM$5.11M
Class
COM
Share
3.8%
Backblaze Inc.COM CL A$4.9M
Class
COM CL A
Share
3.7%
Microsoft Corp.COM$4.17M
Class
COM
Share
3.1%
Veracyte Inc.COM$3.52M
Class
COM
Share
2.6%
Ooma Inc.COM$3.4M
Class
COM
Share
2.6%
Personalis Inc.COM$3.2M
Class
COM
Share
2.4%
Cryoport Inc.COM PAR $0.001$3.14M
Class
COM PAR $0.001
Share
2.4%
Ciena Corp.COM NEW$3.09M
Class
COM NEW
Share
2.3%
Lemaitre Vascular Inc.COM$2.43M
Class
COM
Share
1.8%
Magnite Inc.COM$1.87M
Class
COM
Share
1.4%
Abbott LaboratoriesCOM$1.84M
Class
COM
Share
1.4%
Usio Inc.COM$1.74M
Class
COM
Share
1.3%
Ondas HoldingsCOM NEW$1.66M
Class
COM NEW
Share
1.2%
Neogenomics Inc.COM NEW$1.61M
Class
COM NEW
Share
1.2%
Perion Network LtdSHS NEW$1.6M
Class
SHS NEW
Share
1.2%
Neogen Corp.COM$1.6M
Class
COM
Share
1.2%
Crexendo Inc.COM$1.59M
Class
COM
Share
1.2%
Alphatec Hldgs Inc.COM NEW$1.52M
Class
COM NEW
Share
1.1%
Abbvie Inc.COM$1.34M
Class
COM
Share
1.0%
Creative Realities Inc.COM$1.24M
Class
COM
Share
0.9%
Lucid Diagnostics Inc.COM$1.2M
Class
COM
Share
0.9%
Codexis Inc.COM$1.19M
Class
COM
Share
0.9%
Zeta Global Holdings Corp.CL A$1.1M
Class
CL A
Share
0.8%
Trisalus Life Sciences Inc.COM$1.07M
Class
COM
Share
0.8%
Tela Bio Inc.COM$1.03M
Class
COM
Share
0.8%
Biodesix Inc.COM$1.01M
Class
COM
Share
0.8%
Safe Pro Group Inc.COM$998K
Class
COM
Share
0.8%
Merck & CO Inc.COM$964K
Class
COM
Share
0.7%
Gilead Sciences Inc.COM$912K
Class
COM
Share
0.7%
Viatris Inc.COM$855K
Class
COM
Share
0.6%
Pfizer Inc.COM$813K
Class
COM
Share
0.6%
Blacksky Technology Inc.CL A NEW$803K
Class
CL A NEW
Share
0.6%
Apple Inc.COM$767K
Class
COM
Share
0.6%
Profound Med Corp.COM NEW$760K
Class
COM NEW
Share
0.6%
US BancorpCOM NEW$746K
Class
COM NEW
Share
0.6%
Neuroone Med Technologies COCOM$744K
Class
COM
Share
0.6%
Vida Global Inc.COM$700K
Class
COM
Share
0.5%
Target Corp.COM$620K
Class
COM
Share
0.5%
Owlet Inc.CL A NEW$611K
Class
CL A NEW
Share
0.5%
Elauwit Connection Inc.COM$598K
Class
COM
Share
0.4%
Mdxhealth SASHS NEW$580K
Class
SHS NEW
Share
0.4%
Seagate Technology Hldgs PLORD SHS$507K
Class
ORD SHS
Share
0.4%
Atricure Inc.COM$490K
Class
COM
Share
0.4%

The share class is shown on a wider screen.

The 50 largest of 79 positions by value, with holdings of the same security combined. The 79 largest are in this firm's machine-readable record. Share counts and quarter-on-quarter changes for each position are on EDGAR. View the full information table on EDGAR

This filing

Form
13F-HR
CIK
884300
File number
028-03086
Options
0 call, 0 put
In the 25 largest
77.6%
Prior quarter
$107M at 31 March 2026
Positions opened
5
Positions closed
12

Common questions

What are Perkins Capital Management’s 13F holdings worth?

$133 million across 79 positions for the quarter ended 30 June 2026.

What is Perkins Capital Management’s largest 13F holding?

NATERA INC (COM) was the largest position at $11 million, or 8.3% of reported 13F value, as of 30 June 2026.

How concentrated is Perkins Capital Management’s 13F portfolio?

The ten largest positions accounted for 52.2% of reported value and the twenty-five largest for 77.6%, across 79 positions as of 30 June 2026.

Does Form 13F show everything Perkins Capital Management manages?

No. Form 13F covers only long positions in exchange-traded securities over which the manager has investment discretion, valued at quarter end. It excludes cash, most bonds, private funds, and any assets the firm does not have discretion over, so it is neither the firm's total assets nor any individual client's portfolio.

How often does Perkins Capital Management file its 13F?

Every quarter. Managers file within 45 days of each quarter's end, so the figures are a snapshot that changes between filings. This page shows the quarter ended 30 June 2026.

Answered from this filing and the prior quarter's.

Back to the Perkins Capital Management profile

Sources

  1. Form 13F-HR, accession 0000884300-26-000003, filed 24 July 2026 for the quarter ended 30 June 2026.
  2. Form 13F-HR, accession 0000884300-26-000002, filed 23 April 2026 for the quarter ended 31 March 2026.
  3. All 13F filings by this firm on EDGAR.

Retrieved 14 October 2026. Values are as reported by the filer in whole dollars; percentages and quarter-over-quarter figures are arithmetic on the filed tables.

Report a correction

This page restates a public SEC filing for informational purposes only. It is not a recommendation of any security or of Perkins Capital Management Inc, and Niva is not affiliated with the firm. Holdings change; the filing reflects one quarter-end date.